Article
CSF glucosylsphingosine is a central readout of GCase impairment across genetic and sporadic Parkinson’s disease
2026-06-22
Abstract excerpt
Parkinson’s disease (PD) risk converges on lysosomal biology, including reduced activity of glucocerebrosidase (GCase), encoded by GBA1 . Glucosylsphingosine (GlcSph), a toxic deacylated glycosphingolipid and established target engagement biomarker in Gaucher disease, is difficult to quantify in cerebrospinal fluid (CSF) because of low abundance and isomeric interference. We optimized and qualified targeted LC–MS...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f8438cd7-9f5b-5f90-afcd-0fa336c26180
- DOI
- 10.64898/2026.06.19.733447
